GB1445802A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1445802A
GB1445802A GB1170374A GB1170374A GB1445802A GB 1445802 A GB1445802 A GB 1445802A GB 1170374 A GB1170374 A GB 1170374A GB 1170374 A GB1170374 A GB 1170374A GB 1445802 A GB1445802 A GB 1445802A
Authority
GB
United Kingdom
Prior art keywords
immunoglobulins
animal
human
solution
ethanolamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1170374A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB1445802A publication Critical patent/GB1445802A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB1170374A 1973-03-22 1974-03-15 Pharmaceutical compositions Expired GB1445802A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7311456A FR2222084B1 (xx) 1973-03-22 1973-03-22

Publications (1)

Publication Number Publication Date
GB1445802A true GB1445802A (en) 1976-08-11

Family

ID=9117096

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1170374A Expired GB1445802A (en) 1973-03-22 1974-03-15 Pharmaceutical compositions

Country Status (6)

Country Link
JP (1) JPS49125518A (xx)
BE (1) BE812669A (xx)
DE (1) DE2413641A1 (xx)
FR (1) FR2222084B1 (xx)
GB (1) GB1445802A (xx)
NL (1) NL7403912A (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS548714A (en) * 1977-06-16 1979-01-23 Saikin Kagaku Kenkiyuushiyo Kk Production of specific antiserum
DE2949031A1 (de) * 1978-12-15 1980-07-17 Sandoz Ag Vakzine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1247886A (en) * 1967-10-10 1971-09-29 Sanofi Sa Therapeutic immunoglobulins and process for their production
GB1355962A (en) * 1970-02-27 1974-06-12 Wellcome Found Preparation of immunosuppressive materials
ES388539A1 (es) * 1970-02-27 1974-02-01 Wellcome Found Un metodo de preparacion de un suero antilinfocitivo inmunosupresivo no toxico.
BE786564A (fr) * 1971-07-23 1973-01-22 Upjohn Co Procede de purification des gamma globulines

Also Published As

Publication number Publication date
JPS49125518A (xx) 1974-12-02
BE812669A (fr) 1974-09-23
NL7403912A (xx) 1974-09-24
FR2222084B1 (xx) 1976-05-14
FR2222084A1 (xx) 1974-10-18
DE2413641A1 (de) 1974-10-03

Similar Documents

Publication Publication Date Title
GB1508050A (en) Bovine milk products
JPS63501570A (ja) 免疫治療方法
GB1531762A (en) Cancer antigen cancer therapy and cancer diagnosis
GB1185225A (en) Injectable Adjuvant, method of preparing same and Compositions including such Adjuvant
US3928580A (en) Injectable glycoproteins containing terminal {37 C{38 {0 ends of human immunoglobulins
Freeman et al. Activity of metronidazole against experimental tetanus and gas gangrene
GB1198764A (en) A Urate Oxidase and process for the production thereof
GB1445802A (en) Pharmaceutical compositions
Evans Phagocytosis of murine lymphoma cells by macrophages: I. Factors affecting in vitro phagocytosis
US4374827A (en) Water soluble extract from nonpathogenic aerobic corynebacteria
SE9704737D0 (sv) Immunoglobulin-rich milk, production and use thereof
GB1351006A (en) Water-soluble konjac mannan and a process for the preparation thereof
Ben‐David et al. HL‐A antigen changes in patients treated with chloramphenicol
Brandriss et al. Immunologic cross-reactivities of three diverse penicillins
GB1187830A (en) Pharmaceutical Compositions comprising Polynucleotides
GB1360032A (en) 2-thio-5-azocytosine and its nucleosides
Stainer et al. Isomerization of 11-cis vitamin A in vivo
Spiera et al. Some factors influencing urinary excretion of 3-hydroxyanthranilic acid
SU1162440A1 (ru) Способ лечени инфекционных осложнений у больных с ожогами
SU122251A1 (ru) Способ изготовлени ассоциированной концентрат-вакцины против эмфизематозного карбункула, злокачественного отека и пастереллеза крупного рогатого скота
GR33713B (el) Βελτιωσεις εις τας μεθοδους παραγωγης θεραπευτικων ορων.
Stern Effect of polylysine on immune hemoantibodies in mice
US3523155A (en) Processes for preparation of therapeutic serums
Wise et al. Phenomenon of local skin-reactivity (Shwartzman) to organisms of the brucella group
SU135595A1 (ru) Способ изготовлени вакцины против пастереллеза (холеры) птиц

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee